Alternative plant protection products

The government wishes to use the Green Growth Agreement to encourage that a greater number of alternative low-risk plant protection products are applied authorised. These are substances that could be permitted for use in organic farming, for example. An improvement in the framework conditions for ecological fruit growers, among others, is therefore desirable. However, the aim is also to be able to replace some of the plant protection products that are currently in use with other, less harmful, products.

Obtaining a grant for your application

Yearly until 2015, two calls for grant applications in connection with applying for the authorisation of alternative plant protection products are planned.
Further information and an application form for the next deadline are available here.

What are alternative plant protection products

Alternative plant protection products can consist of for instance plant extracts, microorganisms or insect pheromones. The products can be used in organic farming if they are included in the Regulation on organic farming. However, this is provided that they have been authorised as plant protection products nationally. The objective is to replace products currently in use in conventional farming with alternative products if these have less environmental and human health load.

It is expected that an increase in the number of alternative plant protection products on the Danish market will:

  • increase the incentive to change to organic farming
  • increase the consumption of such products in conventional agriculture, which will thereby increasingly satisfy the principles of Integrated Pest Management
  • reduce the load of plant protection products on the environment and human health.

Initiatives to promote alternative plant protection products

Like in all other EU member states, the industry, when applying for authorisation of new plant protection products in Denmark, they have to undergo two authorisation procedures – an EU procedure and a national procedure. Both are costly for the applicants as they require comprehensive documentation for the risk assessment in relation to human health and the environment and for the assessment of efficacy and residues.
In order to have more alternative products on the Danish market, conditions for firms seeking authorisation should be made more attractive.  This may be achieved by means of:

  • more guidance for applicants with regard to application procedures
  • financial help for providing missing data
  • financial help for the provision of information as needed to complete an application for authorisation
  • short processing times for applications for authorisation

Similar initiatives have in recent years been implemented in the Netherlands, Belgium and the United Kingdom and resulted in increased interest in the authorisation of alternative products.